Clinical Trial Update: Phase I Pharmacokinetic Study (BF-BLOCK) [Phase 1]

View source ↗

Summary

Orion Corporation completed a Phase I pharmacokinetic study of BF-BLOCK for asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• BF-BLOCK

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Asthma | Phase 1 | Status: COMPLETED